Is Female Sex a Risk Factor for Red Blood Cell Alloimmunization After Transfusion? A Systematic Review

Transfusion Medicine Reviews

Volumn 26, Issue 4, 2012, Pages

  Verduin, Esther P ^a   Brand, Anneke ^a   Schonewille, Henk ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN;

ALLOIMMUNIZATION; ANTIBODY SCREENING; ARTICLE; AUTOIMMUNITY; BLOOD GROUP KELL SYSTEM; BLOOD GROUP RH; BLOOD TRANSFUSION; CLINICAL TRIAL (TOPIC); DATA BASE; ERYTHROCYTE; FEMALE; FETUS DEATH; HEMOGLOBINOPATHY; HUMAN; IMMUNIZATION; INCIDENCE; MANTEL HAENSZEL TEST; RISK FACTOR; SEX DIFFERENCE; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW;

EID: 84866439949     PISSN: 08877963     EISSN: 15329496     Source Type: Journal    
DOI: 10.1016/j.tmrv.2011.12.001     Document Type: Article

References (77)

1. Schonewille H. Red blood cell alloimmunization after blood transfusion 2008, University Leiden, Leiden.
2. Bauer M.P., Wiersum-Osselton J., Schipperus M., et al. Clinical predictors of alloimmunization after red blood cell transfusion. Transfusion 2007, 47:2066-2071.
3. Reisner E.G., Kostyu D.D., Phillips G., et al. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987, 30:161-166.
4. Ameen R., Al-Shemmari S., Al-Humood S., et al. RBC alloimmunization and autoimmunization among transfusion-dependent Arab thalassemia patients. Transfusion 2003, 43:1604-1610.
5. Bouman A., Heineman M.J., Faas M.M. Sex hormones and the immune response in humans. Hum Reprod Update 2005, 11:411-423.
6. Nalbandian G., Kovats S. Understanding sex biases in immunity: Effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol Res 2005, 31:91-106.
7. Hughes G.C., Clark E.A. Regulation of dendritic cells by female sex steroids: Relevance to immunity and autoimmunity. Autoimmunity 2007, 40:470-481.
8. Giblett E.R. Blood group alloantibodies: An assessment of some laboratory practices. Transfusion 1977, 17:299-308.
9. Zandman-Goddard G., Peeva E. Shoenfeld: Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372.
10. Nelson J.L., Furst D.E., Maloney S., et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562.
11. Nelson J.L. Maternal-fetal immunology and autoimmune disease: Is some autoimmune disease auto-alloimmune or allo-autoimmune?. Arthritis Rheum 1996, 39:191-194.
12. Scaletti C., Vultaggio A., Bonifacio S., et al. Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens. Arthritis Rheum 2002, 46:445-450.
13. Lo Y.M., Lo E.S., Watson N., et al. Two-way cell traffic between mother and fetus: Biologic and clinical implications. Blood 1996, 88:4390-4395.
14. Khosrotehrani K., Johnson K.L., Cha D.H., et al. Transfer of fetal cells with multilineage potential to maternal tissue. JAMA 2004, 292:75-80.
15. Bianchi D.W., Zickwolf G.K., Weil G.J., et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 1996, 93:705-708.
16. Maloney S., Smith A., Furst D.E., et al. Microchimerism of maternal origin persists into adult life. J Clin Invest 1999, 104:41-47.
17. Spielmann W., Seidl S. Prevalence of irregular red cell antibodies and their significance in blood transfusion and antenatal care. Vox Sang 1974, 26:551-559.
18. Hoeltge G.A., Domen R.E., Rybicki L.A., et al. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995, 119:42-45.
19. Saverimuttu J., Greenfield T., Rotenko I., et al. Implications for urgent transfusion of uncrossmatched blood in the emergency department: The prevalence of clinically significant red cell antibodies within different patient groups. Emerg Med (Fremantle) 2003, 15:239-243.
20. Review Manager (RevMan) [Computer program], Version 5.1 2011, The Nordic Cochrane Center, The Cochrane Collaboration, Copenhagen.
21. Aygun B., Padmanabhan S., Paley C., et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion 2002, 42:37-43.
22. Gader A.G., Al Ghumlas A.K., Al-Momen A.K. Transfusion medicine in a developing country-alloantibodies to red blood cells in multi-transfused patients in Saudi Arabia. Transfus Apher Sci 2008, 39:199-204.
23. Dias Zanette A.M., de Souza G.M., Vilasboas S.L., et al. Alloimmunization and clinical profile of sickle cell disease patients from Salvador-Brazil. Ethn Dis 2010, 20:136-141.
24. Orlina A.R., Unger P.J., Koshy M. Post-transfusion alloimmunization in patients with sickle cell disease. Am J Hematol 1978, 5:101-106.
25. Cox J.V., Steane E., Cunningham G., et al. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988, 148:2485-2489.
26. Le Turdu-Chicot C., Foucan L., Etienne-Julan-Otto M. Séroprevalence virale, transfusion et alloimmunisation chez des adultes drépanocytaires guaduloupenéens. Transfus Clin Biol 2002, 9:115-120.
27. Sakhalkar V.S., Roberts K., Hawthorne L.M., et al. Allosensitization in patients receiving multiple blood transfusions. Ann N Y Acad Sci 2005, 1054:495-499.
28. Wang L.Y., Liang D.C., Liu H.C., et al. Alloimmunization among patients with transfusion-dependent thalassemia in Taiwan. Transfus Med 2006, 16:200-203.
29. Thompson A.A., Cunningham M.J., Singer S.T., et al. Red cell alloimmunization in a diverse population of transfused patients with thalassaemia. Br J Haematol 2011, 153:121-128.
30. Noor Haslina M.N., Ariffin N., Illuni H., et al. Red cell autoantibodies among thalassaemia patients in Hospital Universiti Sains Malaysia. Singapore Med J 2007, 48:922-925.
31. Tahhan H.R., Holbrook C.T., Braddy L.R., et al. Antigen-matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994, 34:562-569.
32. Saied D.A., Kaddah A.M., Badr Eldin R.M., et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent Egyptian thalassemic patients. J Pediatr Hematol Oncol 2011, 33:409-414.
33. Murao M., Viana M.B. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res 2005, 38:675-682.
34. Spanos T., Karageorga M., Ladis V., et al. Red cell alloantibodies in patients with thalassemia. Vox Sang 1990, 58:50-55.
35. Singer S.T., Wu V., Mignacca R., et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 2000, 96:3369-3373.
36. Gupta R., Singh D.K., Singh B., et al. Alloimmunization to red cells in thalassemics: Emerging problem and future strategies. Transfus Apher Sci 2011, 45:167-170.
37. Habibi B., Lecolier B. Inconvenience of planned prophylaxis of transfusion-induced alloimmunization to red cells in chronic renal insufficiency. Rev Fr Transfus Immunohematol 1983, 26:267-277.
38. Novaretti M.C., Sopelete C.R., Velloso E.R., et al. Immunohematological findings in myelodysplastic syndrome. Acta Haematol 2001, 105:1-6.
39. Stiegler G., Sperr W., Lorber C., et al. Red cell antibodies in frequently transfused patients with myelodysplastic syndrome. Ann Hematol 2001, 80:330-333.
40. Seyfried H., Walewska I. Analysis of immune response to red blood cell antigens in multitransfused patients with different diseases. Mater Med Pol 1990, 22:21-25.
41. Brantley S.G., Ramsey G. Red cell alloimmunization in multitransfused HLA-typed patients. Transfusion 1988, 28:463-466.
42. Fluit C.R., Kunst V.A., Drenthe-Schonk A.M. Incidence of red cell antibodies after multiple blood transfusion. Transfusion 1990, 30:532-535.
43. De La Rubia J., Arriaga F., Andreu R., et al. Development of non-ABO RBC alloantibodies in patients undergoing allogeneic HPC transplantation. Is ABO incompatibility a predisposing factor?. Transfusion 2001, 41:106-110.
44. Blumberg N., Ross K., Avila E., et al. Should chronic transfusions be matched for antigens other than ABO and Rho(D)?. Vox Sang 1984, 47:205-208.
45. Baby M., Fongoro S., Cisse M., et al. Frequency of red blood cell alloimmunization in polytransfused patients at the university teaching hospital of Point G, Bamako, Mali. Transfus Clin Biol 2010, 17:218-222.
46. Heddle N.M., Soutar R.L., O'Hoski P.L., et al. A prospective study to determine the frequency and clinical significance of alloimmunization post-transfusion. Br J Haematol 1995, 91:1000-1005.
47. Redman M., Regan F., Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996, 71:216-220.
48. Gonzalez-Porras J.R., Graciani I.F., Perez-Simon J.A., et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D- patients. Transfusion 2008, 48:1318-1324.
49. Mollison P.L., Engelfriet C.P., Contreras M. Blood transfusion in clinical medicine 2005, Blackwell Scientific Publications, London. 11th ed.
50. Sarnaik S., Schornack J., Lusher J.M. The incidence of development of irregular red cell antibodies in patients with sickle cell anemia. Transfusion 1986, 26:249-252.
51. Ramsey G., Cornell F.W., Hahn L.F., et al. Red cell antibody problems in 1000 liver transplants. Transfusion 1989, 29:396-400.
52. Cummins D., Contreras M., Amin S., et al. Red cell alloantibody development associated with heart and lung transplantation. Transplantation 1995, 59:1432-1435.
53. Moreira J.G., Bordin J.O., Kuroda A., et al. Red blood cell alloimmunization in sickle cell disease: The influence of racial and antigenic pattern differences between donors and recipients in Brazil. Am J Hematol 1996, 52:197-200.
54. Shukla J.S., Chaudhary R.K. Red cell alloimmunization in multi-transfused chronic renal failure patients undergoing hemodialysis. Indian J Pathol Microbiol 1999, 42:299-302.
55. So C.C., Wong K.F., Yu P.H., et al. Alloimmunization in Chinese with warm autoimmune haemolytic anaemia-incidence and characteristics. Transfus Med 2000, 10:141-143.
56. Au W.Y., Liu C.L., Lo C.M., et al. Red blood cell alloantibodies and liver transplantation in Chinese patients. Transplantation 2003, 75:1904-1906.
57. Canatan D., Oguz N., Cosan R., et al. Red cell antibodies in patients with β-thalassemia major. Blood Banking and Transfusion Medicine 2003, 1:31-34.
58. van de Watering L., Hermans J., Witvliet M., et al. HLA and RBC immunization after filtered and buffy coat-depleted blood transfusion in cardiac surgery: A randomized controlled trial. Transfusion 2003, 43:765-771.
59. Frohn C., Dumbgen L., Brand J.M., et al. Probability of anti-D development in D- patients receiving D+ RBCs. Transfusion 2003, 43:893-898.
60. Bhatti F.A., Salamat N., Nadeem A., et al. Red cell immunization in beta thalassaemia major. J Coll Physicians Surg Pak 2004, 14:657-660.
61. Bilwani F., Kakepoto G.N., Adil S.N., et al. Frequency of irregular red cell alloantibodies in patients with thalassemia major: A bicenter study. J Pak Med Assoc 2005, 55:563-565.
62. Shariatmadar S., Pyrsopoulos N.T., Vincek V., et al. Alloimmunization to red cell antigens in liver and multivisceral transplant patients. Transplantation 2007, 84:527-531.
63. Yazer M.H., Triulzi D.J. Detection of anti-D in D- recipients transfused with D+ red blood cells. Transfusion 2007, 47:2197-2201.
64. Shamsian B.S., Arzanian M.T., Shamshiri A.R., et al. Frequency of red cell alloimmunization in patients with β-major thalassemia in an Iran referral hospital. Iran J Pediatr 2010, 18:149-153.
65. Thakral B., Saluja K., Sharma R.R., et al. Red cell alloimmunization in a transfused patient population: A study from a tertiary care hospital in north India. Hematology 2008, 13:313-318.
66. Tormey C.A., Fisk J., Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008, 48:2069-2076.
67. Sadeghian M.H., Keramati M.R., Badiei Z., et al. Alloimmunization among transfusion-dependent thalassemia patients. Asian J Transfus Sci 2009, 3:95-98.
68. McPherson M.E., Anderson A.R., Castillejo M.I., et al. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2010, 54:552-558.
69. Natukunda B., Schonewille H., Ndugwa C., et al. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010, 50:20-25.
70. Natukunda B., Schonewille H., van de Watering L., et al. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Vox Sang 2010, 98:167-171.
71. Pahuja S., Pujani M., Gupta S.K., et al. Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian origin. Hematology 2010, 15:174-177.
72. M'baya B., Mfune T., Mogombo E., et al. The prevalence of red cell antigens and antibodies in Malawi. Transfus Med 2009, 20:196-199.
73. Takeshita A., Watanabe H., Fijihara H., et al. Collaborative study of irregular erythrocyte antibodies in Japan: Results from the Japanese study group of allo-immunity and antigen diversity in Asian populations. Transfus Apher Sci 2010, 43:3-8.
74. Platt O.S., Brambilla D.J., Rosse W.F., et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994, 330:1639-1644.
75. Rosse W.F., Gallagher D., Kinney T.R., et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990, 76:1431-1437.
76. Zalpuri S., Zwaginga J.J., le C.S., Elshuis J., et al. Red-blood-cell alloimmunization and number of red-blood-cell transfusions. Vox Sang 2011, [published online].
77. http://data.worldbank.org/indicator/SP.DYN.TFRT.IN.